A sensor that requires no nanoscale patterning detects single molecules of a breast cancer protein at concentrations 250 ...

The Signatera assay showed positive correlations between ctDNA presence and cancer recurrence, suggesting its potential for ...

The new artificial intelligence-based software and robot-assisted biopsy technology helps providers catch and treat lung cancer in its earliest stages.

A blood-based colorectal cancer (CRC) screening test, SimpleScreen™, has shown a significant leap in performance, ...

Breast cancer screening based on individual risk rather than annual screening is safe, effective and preferred by patients, ...

Galleri is a blood test that aims to detect over 50 types of cancer early. It analyzes cell-free DNA (cfDNA) and methylation patterns to identify potential cancer signals. The test is intended for ...

By focusing on the one mole that does not match the rest, doctors are improving early melanoma detection while avoiding ...

A whole-genome sequencing approach shows early promise over current commercial methods for identifying more patients likely ...

Multicancer early detection testing results in extended life-years and reduced cancer treatment costs through earlier diagnosis, leading to a cost-effective option in cancer screening. Objectives: ...

In Washington, D.C., Tallahassee and state capitals throughout the U.S., a new perspective on health care is taking hold. Policymakers are recognizing that we can save money and improve patient ...